首页 | 本学科首页   官方微博 | 高级检索  
检索        

化疗对晚期非小细胞肺癌患者凝血功能的影响
引用本文:徐春华,于力克.化疗对晚期非小细胞肺癌患者凝血功能的影响[J].现代肿瘤医学,2011,19(1):65-66.
作者姓名:徐春华  于力克
作者单位:南京市胸科医院呼吸科,江苏,南京,210029
摘    要:目的:探讨晚期非小细胞肺癌(NSCLC)患者化疗前后凝血指标的变化及临床意义。方法:对60例肺癌患者及20例健康人的血浆凝血酶原时间(PT)、纤维蛋白原(FIB)、部分活化凝血活酶时间(APTT)和D-二聚体(D-D))水平进行测定,同时计数血小板(PLT)。结果:化疗前肺癌患者凝血指标凝血酶原时间、纤维蛋白原、部分活化凝血活酶时间、D-二聚体、血小板与正常对照组比较有显著差异(P<0.05);肺癌患者化疗后与化疗前各项指标相比有显著性差异(P<0.05)。结论:晚期NSCLC患者普遍存在凝血功能异常,化疗可改善患者的凝血功能。

关 键 词:非小细胞肺癌  化疗  凝血指标

The influence of chemotherapy on coagulation function in patients with advanced non-small cell lung cancer
XU Chun-hua,YU Li-ke.The influence of chemotherapy on coagulation function in patients with advanced non-small cell lung cancer[J].Journal of Modern Oncology,2011,19(1):65-66.
Authors:XU Chun-hua  YU Li-ke
Institution:Department of Respiration,Nanjing Chest Hospital,Nanjing 210029,China.
Abstract:Objective:To evaluate the variations of coagulation markers before and after chemotherapy in patients with advanced non-small cell lung cancer.Methods :The plasma levels of coagulation markers were detected in 60 patients with lung cancer and 20 normal controls.Results: Compared with the control group,the mean values of prothrombin time(PT),fibrinogen(FIB),activated partial thromboplastin time(APTT)、D-dimer(D-D) and platelet count(PLT) were significantly increase(P<0.05)in patients with NSCLC.The expressive rates of coagulation markers were lower in post-treatment patients than in pre-treatment samples(P<0.05).Conclusion:Coagulation disorder is common among advanced NSCLC patients.Chemotherapy may improve the coagulation function of patients with NSCLC.
Keywords:non-small cell lung cancer  chemotherapy  coagulation markers
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号